Paul M. Gelb is counsel in the firm's Los Angeles office, concentrating his practice on commercial litigation. He represents clients in a wide variety of matters, including contract, unfair competition, health care, ERISA, pharmaceutical, securities, intellectual property and employment cases, as well as appellate law before the Ninth Circuit and the California Courts of Appeal and the California Supreme Court.
In General. Paul earned his J.D. from Columbia Law School where he was a Harlan Fiske Stone Scholar. He received his B.A., cum laude, from Columbia University with degrees in history and mathematics. Paul lectures frequently on topics of legal interest. He has published a range of articles including "No Safe Harbor for Secondary Infringements" in the Los Angeles Daily Journal, "Patent Licensing After MedImmune"in the American Health Lawyers Association Life Sciences publication, "U.S. Supreme Court Decisions in Teleflex and MedImmune Increase Patent Licensee Power" in The Licensing Journal, and "Reimbursement to Medicare Part D Prescription Drug Plans" as a comprehensive American Health Lawyers Association member briefing.